Medical technologies
-
DePuy Synthes Announces Agreement with Materialise for 3D-Printed Titanium Cranio-Facial Implants
In a development that further underscores ways in which medical devices are being personalized for individual patients, DePuy Synthes, part of the Johnson & Johnson family of companies, announced an agreement with Materialise, a leader in 3D printing, to offer TRUMATCH® titanium 3D-printed implants for use in facial and skull disorders. -
Johnson & Johnson Vision Care Enters Monthly Category with ACUVUE® VITA™ Brand Contact Lenses
Data Shows New Lens Superior to Leading Competitors in Comfort across 30-Day Wearing Cycle -
New Data Show On-Demand, Mealtime Insulin Delivery System Enabled More than 50 Percent of Patients to Report Improved Dose Compliance
Innovative, In-Development Patch Allows Simple and Discreet Dosing and Greater Patient Satisfaction -
DePuy Synthes Companies Announces Acquisition Of Biomedical Enterprises, Inc., A Leader In Small Bone Fixation
Acquisition of Nitinol Implant Company Strengthens Johnson & Johnson Medical Devices Position in Elective Extremity Surgery, the Fastest Growing Segment in Orthopaedics -
Ethicon Announces Agreement To Acquire NeuWave Medical, Inc.
NeuWave Medical Technology Offers Minimally Invasive Intervention Option for Patients with Soft Tissue Lesions -
DePuy Synthes Companies Announces New Strategic Alliance with Experts in Bundled Payments
Part of DePuy Synthes Companies’ Broader Effort to ‘Go Beyond the Implant’ -
New Onetouch Verio Flex™ Blood Glucose Monitoring System with ColorSure™ Technology Takes the Guesswork Out of Blood Sugar Test Results
-- 9 out of 10 People With Diabetes Agree The System’s Simple Color Range Indicator Helps Them Easily Interpret Their Blood Sugar Readings -- -
FDA Approves Animas® Vibe® Insulin Pump and Continuous Glucose Monitoring System For Use in Children
Insulin Pump System Offers Children Ages Two and Older an Integrated Solution for Diabetes Management -
Biosense Webster, Inc. Announces Acquisition of Coherex Medical, Inc.
The addition of the Coherex WaveCrest® Left Atrial Appendage Occlusion System to the company’s portfolio expands range of treatment options for patients with atrial fibrillatio